Table 9.
Comparison of therapy effectiveness for the relapse model
| DMT* | Slope coefficienta | Sample size when DMT* was taken | Sample size when DMT* was not taken | p-value |
|---|---|---|---|---|
| Dimethylfumarat | −0.6918 | 134 | 307 | 0.016 |
| Fingolimod | 0.0423 | 128 | 112 | 0.860 |
| Natalizumab | −0.4376 | 234 | 2182 | 0.019 |
DMT* highest ranked disease modifying therapy.
a Derived from a survey-weighted negative binomial generalized linear model where negative sign indicates lower disease activity